Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.
Politics and Policy
About half of states have transitioned at least some Medicaid beneficiaries away from fee-for-service (FFS) drug programs into drug plans integrated with managed care. Our policy analyst shares why he believes more should do so.
How did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.
Insiders unmask what policy actions will continue and what will develop in the next year.
Experts weigh in on the findings from Managed Healtcare Executive’s 2017 State of the Industry Survey.
Experts share more about Alex Azar’s background and predict what his top agenda items are likely to be.
PBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
Is interoperability in healthcare a dream, or will payers, providers, and technology vendors finally come together to make data more available to one another?
While many analyses of Section 1a of the executive order cite doom and gloom for health plans, four tenuous contingencies all must take place in order for this to occur.
A survey of nearly 200 healthcare executives has interesting findings related to population health management.